Global Biopharmaceutical Logistics Industry

Global Biopharmaceutical Logistics Industry

  • September 2020 •
  • 170 pages •
  • Report ID: 5960814 •
  • Format: PDF
Global Biopharmaceutical Logistics Market to Reach $109.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Biopharmaceutical Logistics estimated at US$78.8 Billion in the year 2020, is projected to reach a revised size of US$109.7 Billion by 2027, growing at aCAGR of 4.8% over the period 2020-2027. Cold Chain Logistics, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$29.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-cold Chain Logistics segment is readjusted to a revised 4.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $23.2 Billion, While China is Forecast to Grow at 4.5% CAGR

The Biopharmaceutical Logistics market in the U.S. is estimated at US$23.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$19.4 Billion by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.We bring years of research experience to this 7th edition of our report. The 170-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,
  • AmerisourceBergen Corporation
  • DB Schenker
  • DHL Express Germany GmbH
  • FedEx Corporation
  • United Parcel Service, Inc. (UPS)